Inflammation is a highly regulated physiologic response that has evolved as a mechanism to respond to infection as well as to promote healing in settings such as tissue injury. CD4 ϩ regulatory T cells (T reg ) are observed at sites of acute and chronic inflammation, 1,2 raising questions as to the molecular basis of their accumulation at these sites. Initial evidence suggested that immunosuppressive activities of T reg are diminished in the presence of inflammatory signals. 3, 4 However, in several studies, the apparently opposite picture emerged, wherein T reg exposed to inflammatory signals retain potent suppressive activity. For instance, murine T reg at sites of viral infection or isolated from inflamed tissues still mediate regulatory function, 5-7 as do human T reg isolated from rheumatoid joints or inflamed colonic mucosa. 8, 9 Collectively, these results point to the possibility that certain signals associated with inflammation might promote T reg activity. Here we unexpectedly identified serum amyloid A (SAA), an acute indicator of inflammation, as a novel factor that induces cellular and cytokine conditions to support the expansion of T reg while maintaining their suppressive capacity.
Introduction
Inflammation is a highly regulated physiologic response that has evolved as a mechanism to respond to infection as well as to promote healing in settings such as tissue injury. CD4 ϩ regulatory T cells (T reg ) are observed at sites of acute and chronic inflammation, 1,2 raising questions as to the molecular basis of their accumulation at these sites. Initial evidence suggested that immunosuppressive activities of T reg are diminished in the presence of inflammatory signals. 3, 4 However, in several studies, the apparently opposite picture emerged, wherein T reg exposed to inflammatory signals retain potent suppressive activity. For instance, murine T reg at sites of viral infection or isolated from inflamed tissues still mediate regulatory function, [5] [6] [7] as do human T reg isolated from rheumatoid joints or inflamed colonic mucosa. 8, 9 Collectively, these results point to the possibility that certain signals associated with inflammation might promote T reg activity. Here we unexpectedly identified serum amyloid A (SAA), an acute indicator of inflammation, as a novel factor that induces cellular and cytokine conditions to support the expansion of T reg while maintaining their suppressive capacity.
Methods
In vivo effects of SAA on T reg proliferation C57BL6/J mice (male, 8-10 weeks old) were purchased from Jackson Laboratory. Mice were injected intraperitoneally with recombinant human SAA (Peprotech, 30 g in 100 l PBS), purified human serum albumin (Sigma-Aldrich, 30 g in 100 l PBS), or endotoxin (Sigma-Aldrich, 0.25 ng in 100 l PBS). Animals were killed 16 hours later; peritoneal cells were harvested and stained for surface and intracellular markers to detect T reg frequency and proliferation. In vivo depletion of monocytes was performed with clodronate liposomes (Encapsula). In these experiments, 400 L of clodronate or empty liposomes were injected intraperitoneally 24 hours before SAA injection.
Flow cytometry and ELISA
Detection of surface markers and intracellular molecules was performed. Antibodies to mouse and human proteins used in these experiments are purchased from Biolegend except for anti-human formyl peptide receptor like-1 (FPRL-1; R&D Systems), anti-human RAGE (receptor of advanced glycation end products), supressor of cytokine signaling 3 (SOCS3; Abcam), and anti-Ki-67, anti-human-pAKT (phosphonylated protein kinase B), pERK1/2 (phosphorylated extracellular signal regulated kinases 1 and 2; BD Biosciences). For in vitro experiments, the relevant subset was labeled with CFSE before suppression assays. Cells were pelleted at various time points and underwent standard staining protocols of the manufacturers. For in vivo experiments, cells were harvested from peritoneal cavity and underwent flow cytometric analysis.
To detect cytokines in the plasma, cytometric bead arrays (BD Biosciences) and ELISA (R&D Systems) were used according to manufacturers' protocols.
Human plasma preparation
The study was approved by the Institutional Review Board at Stanford University. All subjects provided informed consent before participating in the study in accordance with the Declaration of Helsinki. Plasma was prepared from whole, anticoagulated blood within 2 hours after blood draw. Whole blood samples were centrifuged at 25°C at 514g for 5 minutes to remove cells, and then underwent 2 additional rounds of centrifugation at 4°C at 1730g for 5 and 15 minutes, respectively to remove platelets. Final plasma samples were stored at Ϫ80°C until analysis. Depletion of SAA from plasma samples was performed with anti-SAA antibodies (Santa Cruz Biotechnology) via immunoprecipitation for 4 consecutive rounds. Negative control for depletion experiments was performed with L243 (anti-HLA-DR) antibodies.
Human cell isolation
CD4 ϩ T cells were purified with CD4 ϩ Rosette Kit (StemCell Technologies) from buffy coats. The CD4 ϩ T cell fraction was then incubated with The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked ''advertisement'' in accordance with 18 USC section 1734.
anti-CD25 microbeads (Miltenyi Biotech) to isolate CD4 ϩ CD25 ϩ cells. The flow-through fraction after magnetic purification contained CD4 ϩ CD25 Ϫ T eff . All procedures were performed according to manufacturers' standard protocols. CD4 ϩ CD25 ϩ T cells were incubated with anti-CD127-APCs, anti-CD25-PE, and anti-CD4-FITC antibodies (BD Biosciences) before undergoing flow cytometric sorting for CD4 ϩ CD25 ϩ CD127 lo/Ϫ T reg and CD4 ϩ CD25 ϩ CD127 ϩ activated T eff . Purity of sorted cells was confirmed to be higher than 95% by Foxp3 staining (eBioscience; data not shown). Cells were rested for 2 hours in 37°C incubator before being used in suppression assays.
Suppression assays
Standard 3 H-thymidine-based suppression assays were performed. Autologous T reg and T eff were cultured at 3750 cells per 50 l per well in complete media (RPMIϩ10%FBSϩ1%L-glutamine) with allogeneic irradiated CD3-depleted peripheral blood mononuclear cells (APCs), at 37 500 cells per 50l per well. Anti-CD3 antibodies (clone UCHT1; BD Biosciences) were precoated on U-bottom 96 well plates at 5 g/mL for 4 hours at 37°C before suppression assays. Additional media was added so the final volume in each well was 200 l. On day 6, cells were pulsed with 1 Ci 3 H-thymidine (25 l) per well and harvested on day 7 with a Tomtec cell harvester. 3 H-thymidine incorporation was determined using a 1450 microbeta Wallac Trilux liquid scintillation counter.
For suppression assays without APCs, anti-CD3 antibodies at 5 g/mL final concentration (clone UCHT1; BD Biosciences) were plate-bound in U-bottom 96-well plates for 4 hours at 37°C. Soluble anti-CD28 (5 g/mL; BD Biosciences) was added, followed by T eff (40 000 cells per 50 l per well) and T reg (40 000 cells per 50 l per well). For CFSE dilution assay, T reg were labeled with CFSE using Cell Tracer CFSE Cell Proliferation kit (Molecular Probes) at a final concentration of 10M, according to manufacturer's instructions. Assays with labeled cells were performed as described for 3 H-thymidine-based suppression assays.
To evaluate effects of plasma on suppression assays and immune cell cultures, frozen plasma samples were thawed at 25°C and debris were removed with sterile 40m filters (BD Biosciences). All plasma samples were tested in duplicates or triplicates. To control for variations in suppressive and proliferative potentials of T reg and T eff , respectively, both HC and SJIA plasma samples were used in parallel suppression assays with the same set of purified cells for each round of experiments. In addition, fold change in 3 H-thymidine cpm in assays with plasma compared with those in complete media alone, was computed to analyze the effects of plasma in suppression assays or stimulation assays. In CFSE assays, percentage of proliferating cells (shown by dye dilution) was used to analyze the effects of plasma on cell proliferation.
Statistical analysis
All statistical procedures were performed with Prism Version 5.0 software (GraphPad). Data were tested for normality (Koromonov-Smirnov test) and variance equality (Bartlett test) before being subjected to appropriate statistical tests. Differences with P Ͻ .05 were considered statistically significant. Correction for multiple comparisons was performed via Bonferroni method.
Results

SAA induces T reg proliferation
To dissect the effects of molecules associated with inflammation on T reg , we first sought to simulate this environment in vitro using plasma from children with systemic juvenile idiopathic arthritis (SJIA), and auto-inflammatory disease, in which elevated levels of both markers of inflammation and inflammatory cytokines are present. Addition of a titrated volume of SJIA plasma (15%) from subjects with various degrees of disease activity flare (F, active disease), quiescence (Q, inactive disease on medication), or remission (R, inactive disease off medication)], but not healthy control (HC) plasma, to 3 H-thymidine-based suppression assays, stimulated cell proliferation (supplemental Figure 1 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Surprisingly, CFSE-based suppression assays revealed that the presumably anergic population of T reg was proliferating and continued to suppress the proliferation of effector T cells (T eff ; Figure 1A) .
To characterize the factor(s) in SJIA plasma that induced T reg proliferation, we measured the serum levels of various inflammatory markers and found significant increases in some cytokines in plasma samples collected at SJIA flare compared with HC plasma (supplemental Figure 2) . Noticeably, SJIA plasma samples from all disease stages had significantly higher levels of SAA than samples from HC ( Figure 1B ). More importantly, depletion of SAA in SJIA plasma abrogated T reg proliferation ( Figure 1C , supplemental Figure 3 ), suggesting that this acute phase protein is required for the mitogenic effects of SAA.
To determine whether SAA is sufficient to reverse T reg anergy, recombinant SAA was added to suppression assays, in the presence of polymixin to inhibit any contaminating LPS. Recombinant SAA was able to selectively enhance proliferation of T reg without reducing their suppressive activity (Figure 2A) . Furthermore, there was a significant increase in T reg abundance in the peritoneal cavity of SAA-injected mice compared with those injected with a control protein, (purified human serum albumin) or endotoxin at the level found in recombinant SAA (0.25ng/mL; Figure 2B ). Concurrently, a significantly higher percentage of peritoneal T reg from SAAinjected mice expressed the nuclear antigen Ki-67, indicating that they were undergoing cell division ( Figure 2C ). In contrast, SAA injection did not enhance T eff proliferation ( Figure 2C ). Collectively, these results demonstrate that SAA is a novel mitogenic stimulator of T reg .
Mitogenic effects of SAA on T reg requires its interaction with monocytes
It is known that SAA interacts with at least 6 distinct receptors: FPRL-1, CD36, RAGE, TLR2, TLR4, and Tanis, [10] [11] [12] [13] [14] which are found to be expressed at strikingly high levels in monocytes compared with B cells and T cells ( Figure 3A) . To explore the possibility that SAA might act on monocytes to indirectly induce T reg proliferation, we first performed suppression assays with anti-CD3 and anti-CD28 antibodies as T cell stimuli in the absence of APCs. Under this condition, both SJIA plasma-derived and exogenous SAA failed to induce T reg proliferation (supplemental Figure 4) , indicating that cells in the APC mixture mediated the mitogenic effect of SAA on T reg . More importantly, depleting monocytes led to a significant decrease in cell proliferation in SAA OVERRIDES TREG ANERGY 3795 BLOOD, 7 APRIL 2011 ⅐ VOLUME 117, NUMBER 14 For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From suppression assays with SAA derived from SJIA plasma ( Figure  3B ). Conversely, monocytes were sufficient to induce cell proliferation at similar levels to those observed using unfractionated APCs ( Figure 3B ). In contrast, B cells were not required for the mitogenic effects of SAA derived from SJIA plasma on T reg proliferation in suppression assays (supplemental Figure 4B) . To further investigate the role of monocytes on SAA-induced T reg proliferation, we depleted monocytes in vivo with clodronate liposomes (supplemental Figure 4C) and found a significant decrease in T reg abundance and their expression of Ki-67 in the peritoneal cavities of SAA-treated animals ( Figure 3C-D) . Altogether, these results showed that monocytes were essential for the mitogenic effects of SAA on T reg .
Induction of SOCS3 in T reg antagonizes their SAA-driven proliferative response
We next examined the activation state of signaling molecules that have been implicated in mitogenic processes, such as AKT and ERK1/2 in T reg in suppression assays. We found that T reg selectively exhibited increased activation of AKT (pAKT) and ERK1/2 (pEKR1/2) in response to SAA derived from SJIA plasma ( Figure  4A ). Furthermore, T reg also expressed significantly higher levels of pAKT and pERK1/2 than T eff (supplemental Figure 5) . Intriguingly, we found that SOCS3, a member of suppressor of cytokine signaling protein family, 15 was expressed at significantly lower levels in T reg compared with T eff ( Figure 4B) .
To test the hypothesis that the difference in SOC3 expression in T reg and T eff regulates their proliferative selective response to SAA derived from SJIA plasma, we attempted modulated SOCS3 expression in T reg using Forskolin (supplemental Figure 6A) , a reagent known to induce SOCS3 expression in various cell types [16] [17] SOCS3 expression by T reg , initially induced by forskolin, remained at a level comparable to that in T eff during the suppression assays (supplemental Figure 6B-C) . Remarkably, forskolin-treated T reg still suppressed T eff proliferation, but they no longer proliferated in response to SAA derived from SJIA plasma ( Figure 5A ). The increased activation of mitogenic signaling in T reg compared with T eff cocultured in the same assays was also abrogated ( Figure  5B ). Collectively, these results suggested that the level of expression of SOCS3 by Treg regulates the dynamic range of their proliferative response to SAA.
Discussion
In human diseases that are characterized by inflammation, increased numbers of T reg have been found in inflamed tissues where local SAA production occurs. [18] [19] [20] SAA is elevated within the same time-frame of accumulation of T reg during tissue injury. 21, 22 Together with our in vivo data, these observations are consistent with the possibility that early induction of SAA at inflammatory sites, coupled with its effects on innate immune cells, generates a milieu that drives T reg proliferation. Our study also suggests that modulating the level of expression of SOCS3 in T reg and, consequentially, the relative expression of SOCS3 in T reg versus T eff by pharmacologic means abrogates the selective activation of mitogenic signaling pathways in T reg on exposure to the micro-environment generated by interaction between SAA and monocytes. These results imply that maintenance versus resolution of inflammatory processes might depend on the relative responsiveness of proinflammatory/effector and anti-inflammatory/regulatory cell subsets. Reduced SOCS3 expression in regulatory cell subsets, such as T reg , might increase their sensitivity to inflammation-derived mitogenic signals, leading to their rapid activation and effective suppression of inflammatory cell types. It is of interest that mediators that could induce SOCS3 expression, such as IL-10, are also produced by T reg and therefore might serve as negative feedback regulators of T reg proliferation to exert a fine balance on tolerance versus immunity under inflammatory conditions. Inflammation associated with infection or tissue injury affords an opportunity for molecular mimicry or exposure of previously cryptic tissue antigens to increase the risk of autoimmunity. These possibilities highlight the need for timely recruitment and/or expansion of tolerogenic cell subsets at inflammatory sites. The mitogenic effects of SAA on T reg shown here may represent a mechanism for protection against the potential breach of tolerance unleashed by inflammation. 
